SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "(L773:2055 6837 OR L773:2055 6845) "

Search: (L773:2055 6837 OR L773:2055 6845)

  • Result 1-10 of 147
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Abell, J. E., et al. (author)
  • Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective review
  • 2017
  • In: European Heart Journal - Cardiovascular Pharmacotherapy. - : Oxford University Press (OUP). - 2055-6837 .- 2055-6845. ; 3:4, s. 214-220
  • Journal article (peer-reviewed)abstract
    • Aim This retrospective chart review was designed to evaluate physician adherence to the prescribing information for fondaparinux regarding adjunctive anticoagulant use during percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome (ACS). Methods and results Medical record abstractors at each site obtained information regarding the use of fondaparinux and adjunctive anticoagulants during PCI. Physician adherence to fondaparinux prescribing information regarding the administration of an adjunctive anticoagulant during PCI was estimated using generalized estimating equations. This retrospective study, conducted in 2008-2010, included a total of 1056 patient records from 27 sites across 6 countries (Canada, France, Germany, Greece, Poland, and Sweden). Over 98% of patients had been treated with fondaparinux at the recommended 2.5 mg dose. Use of adjunctive anticoagulant during PCI was 97.5%, giving an adjusted adherence rate of 98.8% (95% confidence interval: 0.97-0.99), with 86.3% of patients receiving unfractionated heparin. Although the sub-group of patients with ST-elevation myocardial infarction who underwent primary PCI was too small to make a definitive conclusion, 70.4% of the 159 patients did not receive fondaparinux immediately prior to (<24 h) or during primary PCI, suggesting that their treating physicians may have been adherent to the prescribing information. Conclusion Physician adherence to the prescribing information for adjunctive anticoagulation during PCI in patients with an ACS receiving fondaparinux was high. The results were consistent in each of the six countries and across patient sub-groups.
  •  
2.
  • Agewall, S (author)
  • Adherence to guidelines and registry data
  • 2017
  • In: European heart journal. Cardiovascular pharmacotherapy. - : Oxford University Press (OUP). - 2055-6845 .- 2055-6837. ; 3:4, s. 183-184
  • Journal article (other academic/artistic)
  •  
3.
  •  
4.
  • Agewall, S (author)
  • Anticoagulation, atherosclerosis, and heart failure
  • 2017
  • In: European heart journal. Cardiovascular pharmacotherapy. - : Oxford University Press (OUP). - 2055-6845 .- 2055-6837. ; 3:1, s. 1-2
  • Journal article (other academic/artistic)
  •  
5.
  •  
6.
  • Agewall, S (author)
  • Antiplatelet treatment in coronary syndrome
  • 2021
  • In: European heart journal. Cardiovascular pharmacotherapy. - : Oxford University Press (OUP). - 2055-6845 .- 2055-6837. ; 7:2, s. 81-82
  • Journal article (other academic/artistic)
  •  
7.
  • Agewall, S (author)
  • Atrial fibrillation in registries
  • 2021
  • In: European heart journal. Cardiovascular pharmacotherapy. - : Oxford University Press (OUP). - 2055-6845 .- 2055-6837. ; 7:1, s. 1-2
  • Journal article (other academic/artistic)
  •  
8.
  •  
9.
  • Agewall, S (author)
  • Cardiovascular pharmacotherapy
  • 2018
  • In: European heart journal. Cardiovascular pharmacotherapy. - : Oxford University Press (OUP). - 2055-6845 .- 2055-6837. ; 4:1, s. 1-1
  • Journal article (other academic/artistic)
  •  
10.
  • Agewall, S (author)
  • Cardiovascular pharmacotherapy and real-world data
  • 2018
  • In: European heart journal. Cardiovascular pharmacotherapy. - : Oxford University Press (OUP). - 2055-6845 .- 2055-6837. ; 4:2, s. 65-66
  • Journal article (other academic/artistic)
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 147

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view